​

Baxter (BAX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BAX Stock Forecast

Baxter (BAX) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $23.60, with a high of $28.00 and a low of $20.00. This represents a -6.72% decline from the last price of $25.30.

$15 $18 $21 $24 $27 $30 High: $28 Avg: $23.6 Low: $20 Last Closed Price: $25.3

BAX Stock Rating

Baxter stock's rating consensus is Hold, based on 36 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 15 Buy (41.67%), 20 Hold (55.56%), 1 Sell (2.78%), and 0 Strong Sell (0.00%).

Hold
Total 36 1 20 15 Strong Sell Sell Hold Buy Strong Buy

BAX Price Target Upside V Benchmarks

TypeNameUpside
StockBaxter-6.72%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks6.36%

Price Target Trends

1M3M12M
# Anlaysts1419
Avg Price Target$20.00$24.25$22.32
Last Closing Price$25.30$25.30$25.30
Upside/Downside-20.95%-4.15%-11.78%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 26-211--13
Sep, 261111--13
Aug, 2612121-16
Jul, 26-2111-14
Jun, 26-2111-14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 06, 2026Barclays$20.00$24.36-17.90%-20.95%
Jul 31, 2026Stifel Nicolaus$28.00$26.754.67%10.67%
Jul 28, 2026UBS$25.00$24.492.08%-1.19%
Jul 28, 2026Rick WiseStifel Nicolaus$24.00$23.342.83%-5.14%
Jul 15, 2026Goldman Sachs$21.00$21.80-3.67%-17.00%
Jul 06, 2026Vijay KumarEvercore ISI$24.00$22.228.01%-5.14%
May 04, 2026Barclays$27.00$17.2156.89%6.72%
Feb 17, 2026Goldman Sachs$17.00$20.54-17.23%-32.81%
Feb 16, 2026Danielle AntalffyUBS$19.00$19.79-3.99%-24.90%
Feb 13, 2026Deutsche Bank$20.00$19.234.00%-20.95%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 06, 2026BarclaysOverweightUnderweightinitialise
Oct 05, 2026CitigroupNeutralNeutralhold
Jul 31, 2026CitigroupSellNeutralupgrade
Jul 28, 2026UBSNeutralNeutralhold
Jul 27, 2026Cowen & Co.HoldHoldhold
Jul 15, 2026Goldman SachsNeutralNeutralhold
Jul 06, 2026Evercore ISIOutperformOutperformhold
May 28, 2026CitigroupNeutralSelldowngrade
May 04, 2026BarclaysOverweightOverweighthold
Mar 16, 2026Bank of America SecuritiesNeutralNeutralhold

Financial Forecast

EPS Forecast

$-5 $-2 $1 $4 $7 $10 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.56$-4.83$5.25$-1.27$-1.87---
Avg Forecast$3.60$3.56$2.59$1.83$2.47$2.72$3.15$3.40
High Forecast$3.62$3.60$2.60$1.84$2.54$2.83$3.20$3.46
Low Forecast$3.57$3.48$2.58$1.82$2.40$2.63$3.05$3.30
Surprise %-28.89%-235.67%102.70%-169.40%-175.71%---

Revenue Forecast

$0 $4B $8B $12B $16B $20B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$12.15B$10.06B$10.36B$10.64B$352.00M---
Avg Forecast$12.57B$15.00B$14.74B$10.56B$11.22B$11.71B$12.30B$12.84B
High Forecast$12.63B$15.14B$14.82B$10.58B$11.34B$11.72B$12.33B$13.00B
Low Forecast$12.51B$14.75B$14.72B$10.52B$11.00B$11.70B$12.27B$12.56B
Surprise %-3.38%-32.94%-29.72%0.75%-96.86%---

Net Income Forecast

$-3B $-1B $-300M $800M $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.28B$-2.43B$2.66B$-649.00M$1.14B---
Avg Forecast$1.17B$1.02B$-76.00M$924.32M$1.25B$1.38B$1.58B$1.72B
High Forecast$1.40B$1.23B$-60.80M$929.37M$1.29B$1.43B$1.62B$1.75B
Low Forecast$935.04M$818.87M$-91.20M$919.27M$1.21B$1.33B$1.55B$1.67B
Surprise %9.86%-337.69%-3594.74%-170.21%-9.12%---

BAX Forecast FAQ

Is Baxter stock a buy?

Baxter stock has a consensus rating of Hold, based on 36 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 15 Buy, 20 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Baxter is a neutral investment for most analysts.

What is Baxter's price target?

Baxter's price target, set by 36 Wall Street analysts, averages $23.6 over the next 12 months. The price target range spans from $20 at the low end to $28 at the high end, suggesting a potential -6.72% change from the previous closing price of $25.3.

How does Baxter stock forecast compare to its benchmarks?

Baxter's stock forecast shows a -6.72% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical instruments & supplies stocks industry (6.36%).

What is the breakdown of analyst ratings for Baxter over the past three months?

  • October 2026: 0% Strong Buy, 15.38% Buy, 84.62% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 7.69% Strong Buy, 7.69% Buy, 84.62% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 6.25% Strong Buy, 12.50% Buy, 75.00% Hold, 6.25% Sell, 0% Strong Sell.

What is Baxter’s EPS forecast?

Baxter's average annual EPS forecast for its fiscal year ending in December 2026 is $2.72, marking a -245.45% decrease from the reported $-1.87 in 2025. Estimates for the following years are $3.15 in 2027, and $3.4 in 2028.

What is Baxter’s revenue forecast?

Baxter's average annual revenue forecast for its fiscal year ending in December 2026 is $11.71B, reflecting a 3227.23% increase from the reported $352M in 2025. The forecast for 2027 is $12.3B, and $12.84B for 2028.

What is Baxter’s net income forecast?

Baxter's net income forecast for the fiscal year ending in December 2026 stands at $1.38B, representing an 21.50% increase from the reported $1.14B in 2025. Projections indicate $1.58B in 2027, and $1.72B in 2028.